In response to the global spread of monkeypox, the Indian government has taken decisive action to safeguard its population. Authorities at all ports, airports, and border crossings shared with Pakistan and Bangladesh have been instructed to remain on high alert for incoming international travelers exhibiting symptoms of the virus.
Three major hospitals in the capital, Ram Manohar Lohia Hospital, Safdarjung Hospital, and Lady Hardinge Hospital, have been equipped with specialized facilities dedicated to isolation and treatment of potential monkeypox cases. The Ministry of Health has convened several meetings with leading experts to assess the situation and develop a comprehensive response strategy.
Recognizing the distinct nature of this strain, which differs from earlier variations of monkeypox, the Ministry of Health has also organized meetings with state governments and the National Centre for Disease Control. All entry points into India are currently on high alert. Officials have stressed that monkeypox and COVID-19 are unrelated, and there is no evidence of a connection between the two viruses.
To ensure prompt detection and management of potential cases, nodal officers have been stationed at hospitals nationwide, and testing facilities are available at 32 ICMR (Indian Council of Medical Research) centers. While the symptoms of monkeypox resemble chickenpox, the disease can be potentially fatal. However, health officials have emphasized that the likelihood of a widespread impact in India is low.
On Sunday, Prime Minister’s Principal Secretary, Mr. PK Mishra, led a review meeting to evaluate the country’s preparedness for monkeypox. As a result, rigorous screening measures have been implemented at all entry points to ensure immediate detection and response in the event of any confirmed cases.
